Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
common.study.values.description
“Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial”
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Device - Edwards PASCAL System
Transcatheter mitral valve repair with the Edwards PASCAL System
Device - Abbott Mitraclip System
Transcatheter mitral valve repair with the Abbott Mitraclip System
participant.views.study.view.additional
participant.views.study.view.scientific-title
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
common.study.values.clinical-trial-id
NCT03706833
participant.views.study.view.id
eXD5We
